Cite
HARVARD Citation
Aldea, M. et al. (2020). ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases. European oncology & haematology. 16 (1), pp. 18-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aldea, M. et al. (2020). ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases. European oncology & haematology. 16 (1), pp. 18-. [Online].